A clinical study on the management of type 2 Diabetes Mellitus with Nisha katakadi Niruha basti and Dhanvantaram ghritha Matrabasti followed by Saptachakra Kashaya as shamanoushadi with two parellel groups A and B respctively with which only patient is blinded.

A Single blind Double Armed Clinical study in the management of type 2 Diabetes Mellitus with Nisha katakadi Niruha basti and Dhanvantaram ghritha Matrabasti along with Saptachakra Kashaya

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/07/020314

Enrollment

100

Registered

2019-07-22

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

Intervention1: Study group GROUP A NIRUHA BASTI Duration of therapy 10 Days SHAMANOUSHADI SAPTACHAKRA KASHAYA Dose 25ml Duration of therapy 30 Days GROUP B MATRA BASTI Duration of therapy 10 Days

Eligibility

Inclusion criteria

Inclusion criteria: Aged between 18 to 60 yrs Patients diagnosed to be suffering from madhu meha having classical signs and Symptoms like Prabhoota mootrata kshuda adhikya Pippasa adhikya Dourbalya Shareera bhara haani Kara pada daha Kara pada suptata Diagnosed cases of TypeII Diabetes Mellitus Patients of either sex will be taken Both newly diagnosed & treated patients of age group between 18 to 60 years Patients of Diabetes Mellitus having Fasting Blood Sugar greater than equal to 126mg per dl to less than equal to 180mg per dl, Post Prandial Blood Sugar greater than equal to 140mg per dl to less than equal to 280mg per dl and raised urine sugar values Patients with other systemic disease which will not interfere with present treatment HbAlc

Exclusion criteria

Exclusion criteria: Patient with other systemic diseases FBS less than 126 mg per dl and more than 180 mg per dl PPBS less than 140 mg per dl and more than 280 mg per dl

Design outcomes

Primary

Measure	Time frame
Change in laboratory parameters after shodhana and shamana on 45th dayTimepoint: 45th day	—

Secondary

Measure	Time frame
Change in the laboratory parameters 10th day and 30th day after shodhana Timepoint: End of 10th day and 30th day	—

Countries

India

Contacts

Public ContactDr Manjula Karlwad

AYURVEDA MAHAVIDYALAYA AND HOSPITAL

drmanjulakb@gmail.com9916259601

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026